Literature DB >> 23417918

Preoperative PET/CT in early-stage breast cancer: is the TNM classification enough?

L Gilardi, L Fumagalli, G Paganelli.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23417918     DOI： 10.1093/annonc/mdt004

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer.

Authors:  Koosha Paydary; Siavash Mehdizadeh Seraj; Mahdi Zirakchian Zadeh; Sahra Emamzadehfard; Sara Pourhassan Shamchi; Saeid Gholami; Thomas J Werner; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

2.  18F-FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer.

Authors:  Gary A Ulaner; Raychel Castillo; Jonathan Wills; Mithat Gönen; Debra A Goldman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-29       Impact factor: 9.236

3.  (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.

Authors:  Gary A Ulaner; Raychel Castillo; Debra A Goldman; Jonathan Wills; Christopher C Riedl; Katja Pinker-Domenig; Maxine S Jochelson; Mithat Gönen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-30       Impact factor: 9.236

4.  Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.

Authors:  Christopher C Riedl; Elina Slobod; Maxine Jochelson; Monica Morrow; Debra A Goldman; Mithat Gonen; Wolfgang A Weber; Gary A Ulaner
Journal:  J Nucl Med       Date:  2014-09-11       Impact factor: 10.057
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.